期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非小细胞肺癌中ERCC1亚型表达及其功能的观察

Detection of ERCC1 Isoform Expression and Its Function in Non-Small Cell Lung Cancer
下载PDF
导出
摘要 1文献来源 Friboulet L, Olaussen KA, Pignon JP, et al. ERCC1 isoform expression and DNA repair in non- small-cell lung cancer I J]. N Engl J Med,2013,368 （12）：1101-1110.
作者 韩宝惠 郭珑华
机构地区 上海市胸科医院肺内科 广东省人民医院肿瘤中心
出处 《循证医学》 CSCD 2013年第4期202-206,共5页 The Journal of Evidence-Based Medicine
关键词 非小细胞肺癌 核苷酸切除修复交叉互补基因1 免疫组织化学法 non-small cell lung cancer excision repair cross-complementation group 1 （ERCC 1 ） immunohistochemistry
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant Cisplatin evaluation: A pooled analysis by the LACE Collaborative Group [ J ]. J Clin Oncol, 2008,26 (21 ) : 3552 - 3559.
  • 2Rosell R, Mendez P, Isla D, et al. Platinum resistancerelated to a functional NER pathway [J]. J Thorac Oncol, 2007,2(12) : 1063-1066.
  • 3Bergstralh DT, Sekelsky J. Interstrand crosslink repair: Can XPF-ERCC1 be let off the hook? [J]. Trends Genet, 2008, 24(2) :70-76.
  • 4Yin J, Vogel U, Guo L, et al. Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population [J]. Cancer Genet Cytogenet, 2006,164( 1 ) : 66-70.
  • 5Krawczyk P, Wojas-Krawczyk K, Mlak R, et al. Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer——A pilot study [J]. Foha Histochem Cytobiol, 2012,50( 1 ) : 80-86.
  • 6Cheng J, Ha M, Wang Y, et al. A Cl18T polymorphism of ERCC1 and response to Cisplatin chemotherapy in patients with late-stage non-small cell lung cancer [J]. J Cancer Res Clin Oncol, 2012, 138(2) :231-238.
  • 7Su C, Zhou S, Zhang L, et al. ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non- small cell lung cancer [J]. Med Oncol, 2011,28 (4): 1411- 1417.
  • 8Vogel U, Nexo BA, Tjonneland A, et al. ERCC1, XPD and RA1 mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes [Jl. Mutat Res, 2006,593(1-2) : 88-96.
  • 9Yan D, Wei P, An G, et al. Prognostic potential of ERCC1 protein expression and clinieopathologic factors in stage m/N2 non-small cell lung cancer [J]. J Thorae Cardiovasc Surg, 2013,8(1):149.
  • 10Reynolds C, Obasaju C, Schell M J, et al. Randomized phase trial of Gemcitabine-based chemotherapy with in situ RRMI and ERCC1 protein levels for response prediction in non-small-cell lung cancer [J]. J Clin 0ncol,2009,27 (34) : 5808-5815.
循证医学
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部